drugset / Trial / NCT01612507
A Study to Assess Safety, Tolerability and Pharmacokinetics of Ceftaroline in Healthy Subjects
RandomizedParallel-groupTriple-blindBasic science
Summary
The purpose of this study is to assess the safety, tolerability, and pharmacokinetics of different dose regimens of Ceftaroline
Timeline
- Start
- 2012-07
- Primary completion
- 2012-11
- Completion
- 2012-11
Publications
- Das S, Li J, Iaconis J, Zhou D, Stone GG, Yan JL, Melnick D. Ceftaroline fosamil doses and breakpoints for Staphylococcus aureus in complicated skin and soft tissue infections. J Antimicrob Chemother. 2019 Feb 1;74(2):425-431. doi: 10.1093/jac/dky439.
- Yang L, Sunzel M, Xu P, Edeki T, Wilson D, Li J, Li H. Evaluation of the pharmacokinetics and safety of single and multiple ceftaroline fosamil infusions in healthy Chinese and Western subjects. Int J Clin Pharmacol Ther. 2015 Aug;53(8):681-91. doi: 10.5414/CP202343.
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Ceftaroline fosamil | Other / unclassified | 600 mg | Intravenous |
Indications
No indication recorded.